Virus Dataset Sample Info

> Dataset: 29684083 Search Result


Summary
Item Summary
Project 29684083
Virus Name HIV
Sample Number 100
Disease HIV-1 infection
Country Cyprus
Data Link https://www.ncbi.nlm.nih.gov/nuccore/?term=KJ635931:KJ636030[pacc]

Sample
ID Sample ID Age Gender Origin Detail
1 CY269 45 M Cyprus View
2 CY270 67 M Cyprus View
3 CY271 23 F Cameroon View
4 CY272 28 F Cameroon View
5 CY273 32 M Cyprus View
6 CY274 53 M U.K. View
7 CY275 25 M Cyprus View
8 CY276 22 M Cyprus View
9 CY277 17 M Cyprus View
10 CY278 50 M Cyprus View
11 CY281 55 F Cyprus View
12 CY282 50 M Cyprus View
13 CY285 25 M Romania View
14 CY286 25 M Cyprus View
15 CY287 28 M Cyprus View
16 CY288 36 M Cyprus View
17 CY289 22 F Romania View
18 CY290 25 M Cyprus View
19 CY291 38 M Cyprus View
20 CY292 26 F Lithuania View
21 CY293 36 M Cyprus View
22 CY294 27 M Cyprus View
23 CY295 31 M Cyprus View
24 CY296 18 M Cyprus View
25 CY299 39 M Cameroon View
26 CY301 39 F Romania View
27 CY302 24 M Romania View
28 CY305 33 M Cyprus View
29 CY307 31 M Togo View
30 CY308 36 M Cyprus View
31 CY310 40 M Cyprus View
32 CY311 43 F Cyprus View
33 CY313 48 M Cyprus View
34 CY314 47 F Romania View
35 CY315 37 M Romania View
36 CY316 70 F U.K. View
37 CY317 23 M Cyprus View
38 CY318 36 F Ukraine View
39 CY319 34 F Romania View
40 CY320 28 M Romania View
41 CY321 32 M Occupied Cyprus View
42 CY322 18 M Cyprus View
43 CY323 23 F Romania View
44 CY324 39 M Greece View
45 CY325 28 F Romania View
46 CY328 29 F Mali View
47 CY329 29 M Cyprus View
48 CY331 45 M Cyprus View
49 CY332 25 M Cyprus View
50 CY333 53 F Cyprus View
51 CY335 35 M Cyprus View
52 CY336 25 M Cyprus View
53 CY337 33 M Cyprus View
54 CY338 32 M Cyprus View
55 CY339 39 F Cyprus View
56 CY340 31 F Cameroon View
57 CY341 37 M Cyprus View
58 CY342 40 M Cyprus View
59 CY343 50 M Cyprus View
60 CY345 33 M Cyprus View
61 CY346 41 M Greece View
62 CY347 27 M Greece View
63 CY348 23 F Romania View
64 CY349 36 M Serbia View
65 CY350 28 M Cyprus View
66 CY351 27 M Cyprus View
67 CY352 30 M Cyprus View
68 CY353 37 M Cyprus View
69 CY354 30 M Cyprus View
70 CY355 30 M Bulgaria View
71 CY356 28 M Cyprus View
72 CY357 52 M Cyprus View
73 CY359 52 M Ukraine View
74 CY362 48 F Ukraine View
75 CY363 32 M Cyprus View
76 CY364 38 M Cyprus View
77 CY365 24 M Cyprus View
78 CY367 43 M U.K. View
79 CY368 33 M Cyprus View
80 CY369 29 M Greece View
81 CY370 47 M Cyprus View
82 CY371 25 M Cyprus View
83 CY372 47 M Cyprus View
84 CY373 55 M Cyprus View
85 CY374 28 M Cyprus View
86 CY375 38 M Bulgaria View
87 CY376 27 M Cyprus View
88 CY377 56 M Cyprus View
89 CY378 53 M Cyprus View
90 CY379 29 M Cyprus View
91 CY380 35 M Kurdistan View
92 CY381 37 F Kurdistan View
93 CY382 26 M Cyprus View
94 CY383 46 M Cyprus View
95 CY384 74 M Cyprus View
96 CY385 31 M Greece View
97 CY386 23 F Romania View
98 CY387 25 F Mali View
99 CY388 37 M Cyprus View
100 CY389 32 M Cameroon View

Literature
Item Summary
PMID 29684083
Title HIV-1 transmission networks across Cyprus (2010-2012).
Abstract A molecular epidemiology study of HIV-1 infection was conducted in one hundred diagnosed and untreated HIV-1-infected patients in Cyprus between 2010 and 2012, representing 65.4% of all the reported HIV-1 infections in Cyprus in this three-year period, using a previously defined enrolment strategy. Eighty-two patients were newly diagnosed (genotypic drug resistance testing within six months from diagnosis), and eighteen patients were HIV-1 diagnosed for a longer period or the diagnosis date was unknown. Phylogenetic trees of the pol sequences obtained in this study with reference sequences indicated that subtypes B and A1 were the most common subtypes present and accounted for 41.0 and 19.0% respectively, followed by subtype C (7.0%), F1 (8.0%), CRF02_AG (4.0%), A2 (2.0%), other circulating recombinant forms (CRFs) (7.0%) and unknown recombinant forms (URFs) (12%). Most of the newly-diagnosed study subjects were Cypriots (63%), males (78%) with median age 39 (Interquartile Range, IQR 33-48) reporting having sex with other men (MSM) (51%). A high rate of clustered transmission of subtype B drug-sensitive strains to reverse transcriptase and protease inhibitors was observed among MSM, twenty-eight out of forty-one MSM study subjects (68.0%) infected were implicated in five transmission clusters, two of which are sub-subtype A1 and three of which are subtype B strains. The two largest MSM subtype B clusters included nine and eight Cypriot men, respectively, living in all major cities in Cyprus. There were only three newly diagnosed patients with transmitted drug resistant HIV-1 strains, one study subject from the United Kingdom infected with subtype B strain and one from Romania with sub-subtype A2 strain, both with PI drug resistance mutation M46L and one from Greece with sub-subtype A1 with non-nucleoside reverse transcriptase inhibitors (NNRTI) drug resistance mutation K103N.